BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34728108)

  • 1. Sentinel lymph node biopsy for stage II endometrial cancer: Recent utilization and outcome in the United States.
    Matsuo K; Klar M; Khetan VU; Violette CJ; Nusbaum DJ; Muderspach LI; Roman LD; Wright JD
    Gynecol Oncol; 2022 Jan; 164(1):46-52. PubMed ID: 34728108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-level trends and outcomes of sentinel lymph node biopsy in vulvar cancer surgery in the United States.
    Brunette LL; Khetan VU; Deshpande RR; Nusbaum DJ; Klar M; Roman LD; Wright JD; Matsuo K
    Gynecol Oncol; 2022 Mar; 164(3):651-657. PubMed ID: 35031190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake in sentinel lymph node biopsy for endometrial cancer with T3 classification.
    Matsuo K; Klar M; Khetan VU; Vallejo A; Violette CJ; Tavakoli A; Nusbaum DJ; Roman LD; Wright JD
    Gynecol Oncol; 2022 May; 165(2):361-368. PubMed ID: 35272876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes for patients with high-risk endometrial cancer undergoing sentinel lymph node assessment versus full lymphadenectomy.
    Holtzman S; Stoffels G; Flint M; Carr C; Prasad-Hayes M; Zeligs K; Blank SV
    Gynecol Oncol; 2023 Jul; 174():273-277. PubMed ID: 37270906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between sentinel lymph node biopsy and micrometastasis in endometrial cancer.
    Matsuo K; Klar M; Khetan VU; Violette CJ; Youssefzadeh AC; Yessaian AA; Roman LD
    Eur J Obstet Gynecol Reprod Biol; 2022 Aug; 275():91-96. PubMed ID: 35763967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of sentinel lymph node biopsy in cervical cancer surgery: Recent U.S. trends.
    Matsuo K; Klar M; Ciccone MA; Nusbaum DJ; Shimada M; Roman LD; Wright JD
    Eur J Surg Oncol; 2022 Jun; 48(6):1407-1413. PubMed ID: 35216862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma.
    Schlappe BA; Weaver AL; McGree ME; Ducie J; Zahl Eriksson AG; Dowdy SC; Cliby WA; Glaser GE; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2020 Jan; 156(1):62-69. PubMed ID: 31776037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of sentinel lymph node biopsy in the early ovarian cancer surgery.
    Matsuo K; Klar M; Barakzai SK; Jooya ND; Nusbaum DJ; Shimada M; Roman LD; Wright JD
    Arch Gynecol Obstet; 2023 Feb; 307(2):525-532. PubMed ID: 35595998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of prognostic value of lymphovascular space invasion in patients with endometrial cancer and negative sentinel lymph nodes.
    Matanes E; Eisenberg N; Lau S; Salvador S; Ferenczy A; Pelmus M; Gotlieb WH; Kogan L
    Gynecol Oncol; 2021 Aug; 162(2):256-261. PubMed ID: 34119364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node mapping alone compared to more extensive lymphadenectomy in patients with uterine serous carcinoma.
    Basaran D; Bruce S; Aviki EM; Mueller JJ; Broach VA; Cadoo K; Soslow RA; Alektiar KM; Abu-Rustum NR; Leitao MM
    Gynecol Oncol; 2020 Jan; 156(1):70-76. PubMed ID: 31739992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of progression-free survival outcome of sentinel node biopsy without ultrastaging versus lymphadenectomy in endometrial cancer: a propensity-matched analysis.
    Lee D; Kim YN; Cho SH; Yoon HS; Kim YT; Kim S; Kim SW
    J Gynecol Oncol; 2023 Nov; 34(6):e79. PubMed ID: 37477102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization and Outcomes of Sentinel Lymph Node Biopsy for Early Endometrial Cancer.
    Matsuo K; Klar M; Nusbaum DJ; Hasanov MF; Vallejo A; Ciesielski KM; Muderspach LI; Roman LD; Wright JD
    Obstet Gynecol; 2022 May; 139(5):809-820. PubMed ID: 35576340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The added value of sentinel node mapping in endometrial cancer.
    Kogan L; Matanes E; Wissing M; Mitric C; How J; Amajoud Z; Abitbol J; Yasmeen A; López-Ozuna V; Eisenberg N; Lau S; Salvador S; Gotlieb WH
    Gynecol Oncol; 2020 Jul; 158(1):84-91. PubMed ID: 32349874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease.
    Ducie JA; Eriksson AGZ; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Soslow RA; Keeney GL; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2017 Dec; 147(3):541-548. PubMed ID: 28965698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does sentinel node mapping impact morbidity and quality of life in endometrial cancer?
    Goncalves BT; Dos Reis R; Ribeiro R; Moretti-Marques R; Schamme FK; Oliveira GS; Tsunoda AT; Alvarenga-Bezerra V; Lopes A; Pastore CBP; Kumagai LY; Faloppa CC; Mantoan H; Badiglian-Filho L; De Brot L; Andrade CEMC; Baiocchi G
    Int J Gynecol Cancer; 2023 Oct; 33(10):1548-1556. PubMed ID: 37699707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel Lymph Node Sampling as an Alternative to Lymphadenectomy in Patients With Endometrial Cancer and Obesity.
    Matanes E; Eisenberg N; Amajoud Z; Gupta V; Yasmeen A; Ismail S; Racovitan F; Raban O; Lau S; Salvador S; Gotlieb WH; Kogan L
    J Obstet Gynaecol Can; 2021 Oct; 43(10):1136-1144.e1. PubMed ID: 33984524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel Lymph Node Mapping vs Systematic Lymphadenectomy for Endometrial Cancer: Surgical Morbidity and Lymphatic Complications.
    Accorsi GS; Paiva LL; Schmidt R; Vieira M; Reis R; Andrade C
    J Minim Invasive Gynecol; 2020; 27(4):938-945.e2. PubMed ID: 31421249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing isolated tumor cells in regional lymph nodes of early endometrial cancer.
    Matsuo K; Khetan VU; Brunette LL; Jooya ND; Klar M; Wright JD; Roman LD
    Gynecol Oncol; 2022 May; 165(2):264-269. PubMed ID: 35232589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node evaluation in high-risk early stage endometrial cancer: A multi-institutional retrospective analysis comparing the sentinel lymph node (SLN) algorithm and SLN with selective lymphadenectomy.
    Buda A; Gasparri ML; Puppo A; Mereu L; De Ponti E; Di Martino G; Novelli A; Tateo S; Muller M; Landoni F; Papadia A
    Gynecol Oncol; 2018 Aug; 150(2):261-266. PubMed ID: 29887483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy.
    Schlappe BA; Weaver AL; Ducie JA; Eriksson AGZ; Dowdy SC; Cliby WA; Glaser GE; Soslow RA; Alektiar KM; Makker V; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2018 Nov; 151(2):235-242. PubMed ID: 30177461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.